Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 689458
                    [Title] => Roche bares study results on lung cancer medicine
                    [Summary] => 
Roche announced this week the final results from a randomized, multi-center, double-blind Phase II study with its investigational personalized medicine, MetMAb, in people with previously treated advanced non-small cell lung cancer (NSCLC).
                    [DatePublished] => 2011-05-26 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

LUNG CANCER RESEARCH

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 689458
                    [Title] => Roche bares study results on lung cancer medicine
                    [Summary] => 
Roche announced this week the final results from a randomized, multi-center, double-blind Phase II study with its investigational personalized medicine, MetMAb, in people with previously treated advanced non-small cell lung cancer (NSCLC).
                    [DatePublished] => 2011-05-26 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Roche bares study results on lung cancer medicine

May 26, 2011 - 12:00am

Roche announced this week the final results from a randomized, multi-center, double-blind Phase II study with its investigational personalized medicine, MetMAb, in people with previously treated advanced non-small...

Science and Environment